For seventy years, a form of diabetes born not from biology's misfiring but from the quiet violence of hunger has existed at the margins of medical recognition. In 2025, the International Diabetes Federation formally acknowledged type 5 diabetes as a distinct disease, giving a name and institutional weight to a condition that may affect up to 25 million people — most of them living where food itself is uncertain. The act of naming is not merely administrative; it is the first condition for care, and for millions in Asia and Africa, it arrives long overdue.
IDF Officially Recognizes Type 5 Diabetes Linked to Malnutrition
Up to 25 million people worldwide, primarily in low- and middle-income countries in Asia and Africa, are affected by type 5 diabetes, often experiencing food insecurity and misdiagnosis.
Insulin therapy can trigger dangerous drops in blood sugar, particularly in people who lack reliable access to food.
Mark
So the IDF recognized this in 2025—but the WHO had already recognized it back in the 1980s and then walked it back. What changed their minds?
Mimi
The evidence base got stronger. Researchers did more studies showing the distinct mechanism—how malnutrition damages the pancreas itself, not just the body's response to insulin. And there's been more clinical observation in places where it's actually common.
Luke
But we should be careful here. The source says studies "suggest" the mechanism. It's a working theory, not proven. And that Indian study was small. We don't have a complete picture yet.
Mark
Why did the WHO pull the recognition in 1999 in the first place?
Mimi
They said there wasn't enough evidence. It was a genuine scientific disagreement—people couldn't agree on how to diagnose it or treat it. Without those standards, it's hard to call something a disease.
Luke
Right. And we should note that even now, the IDF is still working on formal diagnostic criteria. So in some sense, they've recognized it before fully defining it.
Mark
That seems backwards.
Mimi
It does, but it's also pragmatic. Twenty-five million people are affected. Waiting for perfect criteria means those people keep getting misdiagnosed and mistreated. Sometimes you have to name something to start studying it properly.
Mark
The warning about insulin—that's the part that really stuck with me. Using insulin in a food-insecure population sounds like it could be genuinely harmful.
Mimi
Exactly. If you give someone insulin but they can't reliably eat, their blood sugar can crash dangerously. And if they can't check their glucose regularly, they're flying blind.
Luke
That's a real clinical problem, but it's also a poverty problem. The issue isn't the insulin itself—it's the conditions these people live in.
Mark
So what does the working group actually do now?
Mimi
They're building the infrastructure: diagnostic standards, treatment guidelines, a registry to track cases globally, training for doctors. Basically, they're trying to make sure the next doctor who sees someone with this doesn't mistake it for type 2.
Luke
But that only works if those guidelines actually reach the clinics in Asia and Africa where most of these patients are. Implementation is the hard part.
O Pulso
- A disease first observed in 1955 spent decades without a stable identity, misclassified and mistreated while the people it afflicted had no recourse to correct the record.
- Up to 25 million people — concentrated in the food-insecure regions of Asia and Africa — have been living with a condition that medicine repeatedly failed to see clearly, often receiving treatments designed for entirely different diseases.
- The danger of misdiagnosis is not abstract: insulin therapy administered without accounting for food insecurity can trigger life-threatening drops in blood sugar in patients who cannot reliably eat or monitor themselves.
- The IDF has launched a working group to build diagnostic criteria, treatment protocols, and a global research registry — the scaffolding of recognition that must now be erected before care can follow.
- Whether this recognition translates into reach depends on the WHO and other institutions joining the effort; without them, the framework risks remaining a document rather than a lifeline.
For seventy years, a form of diabetes born not from biology's misfiring but from the quiet violence of hunger has existed at the margins of medical recognition. In 2025, the International Diabetes Federation formally acknowledged type 5 diabetes as a distinct disease, giving a name and institutional weight to a condition that may affect up to 25 million people — most of them living where food itself is uncertain. The act of naming is not merely administrative; it is the first condition for care, and for millions in Asia and Africa, it arrives long overdue.
In 2025, the International Diabetes Federation did something medicine had resisted for decades: it officially recognized type 5 diabetes as its own disease. Unlike the more familiar forms, this condition does not arise from the body's failure to produce or respond to insulin in the usual sense — it emerges from chronic malnutrition, from the slow damage that prolonged hunger inflicts on the pancreas and its capacity to regulate blood sugar. As many as 25 million people are thought to live with it, most of them in low- and middle-income countries across Asia and Africa where food insecurity is not an exception but a condition of daily life.
The disease has a long and fractured history. Physicians first described it in Jamaica in 1955, and the WHO briefly granted it formal status in the 1980s under the name malnutrition-related diabetes mellitus — only to withdraw that recognition in 1999, citing insufficient evidence. For the following quarter-century, the medical community remained divided, and patients paid the price. Because type 5 shares surface features with type 1 and type 2 diabetes, it is frequently misdiagnosed, leading to treatment plans that can be not just ineffective but actively harmful. Research from southern India helped clarify a key distinction: these patients are insulin-deficient but insulin-sensitive, a profile that sets them apart from type 2 patients and demands a different clinical approach.
The IDF's recognition has set concrete work in motion. A working group led by endocrinologist Meredith Hawkins is developing formal diagnostic criteria, treatment guidelines, and a global registry to track cases and build the evidence base. The group has also flagged a specific hazard: insulin therapy, if applied without careful attention to a patient's food access and ability to monitor glucose, can cause dangerous hypoglycemia in people who cannot reliably eat. The risk is structural, woven into the very conditions that produce the disease.
What the recognition ultimately delivers depends on whether the WHO and other major institutions follow. Without that broader coordination, the guidelines and registries may never reach the communities they are meant to serve — people whose diabetes is not a product of genetics or lifestyle, but of not having enough to eat.
In 2025, the International Diabetes Federation took a step that had been pending for decades: it officially recognized type 5 diabetes as a distinct disease. This form of diabetes emerges not from the body's failure to produce insulin or its resistance to it, but from the grinding reality of chronic malnutrition. The IDF's decision matters because up to 25 million people worldwide are thought to carry this condition, most of them living in low- and middle-income countries across Asia and Africa where food insecurity remains severe and persistent.
The disease itself is not new to medicine. Doctors first identified and described it in Jamaica in 1955, observing a pattern of diabetes that seemed tied directly to prolonged hunger and nutritional deprivation. By the 1980s, the World Health Organization had formally recognized it as a separate classification, calling it malnutrition-related diabetes mellitus. But in 1999, the WHO withdrew that recognition, citing insufficient evidence to support it as a distinct entity. For the next quarter-century, the medical world remained fractured on the question: was this truly a separate disease, or simply diabetes wearing a different mask?
Scientists studying the condition in both laboratory animals and human patients have developed a working theory about what happens inside the body. Chronic nutrient deficiency appears to damage the pancreas in lasting ways, impairing its ability to manufacture and release insulin, and disrupting the organ's capacity to regulate blood glucose. One hypothesis centers on impaired pancreatic development—the organ simply does not form properly when the body is starved of essential nutrients during critical periods. A small study conducted in southern India revealed a crucial distinction: patients with malnutrition-related diabetes showed insulin deficiency, but their bodies remained sensitive to the insulin that was present. This differs fundamentally from type 2 diabetes, where the body produces insulin but becomes resistant to it, unable to use it effectively.
The problem of misdiagnosis runs through the entire story. Because type 5 diabetes shares surface similarities with other forms of the disease, it is frequently mistaken for type 1 or type 2, leading to treatment approaches that may be inappropriate or even dangerous. This confusion has real consequences for people already living with food insecurity.
The IDF's recognition has triggered concrete action. The federation established a working group led by endocrinologist Meredith Hawkins to develop formal diagnostic criteria, establish treatment protocols, create a global research registry to track cases, and design training programs for medical workers who encounter these patients. In a review published after the official recognition, Hawkins and her colleagues raised a specific warning: insulin therapy, if used carelessly, can trigger dangerous drops in blood sugar, particularly in people who lack reliable access to food and cannot consistently monitor their glucose levels. The risk is not theoretical—it is embedded in the lived conditions of the people most affected.
What happens next depends on whether other major health organizations, including the World Health Organization itself, follow the IDF's lead. Without broader institutional recognition and coordination, the working group's efforts to standardize diagnosis and treatment may struggle to reach the populations that need them most. The question now is whether this official recognition becomes the beginning of real change in how medicine identifies and treats millions of people whose diabetes is rooted not in genetics or lifestyle, but in the simple, brutal fact of not having enough to eat.
Citações Notáveis
Inappropriate use of insulin can cause hypoglycemia, especially amid food insecurity and limited ability to monitor glucose levels.— Endocrinologist Meredith Hawkins and colleagues, in a review published after the disease's official recognition
Quer a matéria completa?
Leia o original em UA.NEWS ↗
Health & Medicine